Table 1: Baseline clinical characteristics of the intervention and control groups before resveratrol or placebo supplementation.

Control groupIntervention groupP value

Age (yrs) 0.697
Sex (female/male)16/1717/160.806
Duration of disease (yrs) 0.239
Family history of diabetes (yrs) 24 (77.4%)15 (50.0%)0.024*
Smoking (n)4 (12.9%)7 (21.90%)0.348
History of hypertension (n)8 (27.6%)9 (29.0%)0.901

Data is presented as means ± SD. For history of diabetes, smoking, and hypertension, the bracketed value corresponds to the total percentage of participants in respective groups. versus control group.